{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:20:27Z","timestamp":1774408827492,"version":"3.50.1"},"reference-count":34,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1568,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1111\/j.1600-0609.2011.01611.x","type":"journal-article","created":{"date-parts":[[2011,3,21]],"date-time":"2011-03-21T18:31:20Z","timestamp":1300732280000},"page":"496-501","source":"Crossref","is-referenced-by-count":9,"title":["When von Willebrand disease comes into age - a matter of change?"],"prefix":"10.1111","volume":"86","author":[{"given":"Wolfgang","family":"Miesbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Berntorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,5,17]]},"reference":[{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/j.1538-7836.2010.03864.x","article-title":"Health-related quality of life among adult patients with moderate and severe von Willebrand disease","volume":"8","author":"de Wee","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0531-5565(98)00047-3","article-title":"Natural anticoagulants, aging, and thromboembolism","volume":"33","author":"Sagripanti","year":"1998","journal-title":"Exp Gerontol"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.exger.2007.06.014","article-title":"Hemostasis factors and aging","volume":"43","author":"Mari","year":"2008","journal-title":"Exp Gerontol"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1053\/euhj.2001.3237","article-title":"von Willebrand factor and coronary heart disease: prospective study and meta-analysis","volume":"23","author":"Whincup","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB5|cit5","first-page":"39","article-title":"Von Willebrand factor in Italian centenarians","volume":"88","author":"Coppola","year":"2003","journal-title":"Haematologica"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1055\/s-0038-1661557","article-title":"Increase in plasma concentration of plasminogen activator inhibitor, fibrinogen, von Willebrand factor, factor VIII:C and in erythrocyte sedimentation rate with age","volume":"55","author":"Aillaud","year":"1986","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1055\/s-0038-1649589","article-title":"Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study","volume":"70","author":"Conlan","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/1047-2797(92)90100-5","article-title":"The distribution of coagulation factors VII and VIII and fibrinogen in adults over 65 years. Results from the Cardiovascular Health Study","volume":"2","author":"Tracy","year":"1992","journal-title":"Ann Epidemiol"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/j.1365-2516.2009.02051.x","article-title":"Age-dependent increase of FVIII:C in mild haemophilia A","volume":"15","author":"Miesbach","year":"2009","journal-title":"Haemophilia"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2141.1997.1222936.x","article-title":"Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use","volume":"97","author":"Lowe","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1365-2516.2009.02030.x","article-title":"Co-morbidities and bleeding pattern in elderly haemophilia A patients","volume":"15","author":"Miesbach","year":"2009","journal-title":"Haemophilia"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.blre.2006.04.002","article-title":"Assessing bleeding in von Willebrand disease with bleeding score","volume":"21","author":"Tosetto","year":"2007","journal-title":"Blood Rev"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2516.2008.01901.x","article-title":"Treatment and prevention of acute bleedings in von Willebrand disease - efficacy and safety of Wilate, a new generation von Willebrand factor\/factor VIII concentrate","volume":"15","author":"Berntorp","year":"2009","journal-title":"Haemophilia"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB14|cit14","volume-title":"GeneReviews [Internet]","author":"Goodeve","year":"2009"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1111\/j.1538-7836.2006.02179.x","article-title":"The von Willebrand disease prophylaxis network: exploring a treatment concept","volume":"4","author":"Berntorp","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/07853890701513738","article-title":"Management of inherited von Willebrand disease in 2007","volume":"39","author":"Federici","year":"2007","journal-title":"Ann Med"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1365-2516.2002.00672.x","article-title":"Guidelines for the diagnosis and management of von Willebrand disease in Italy","volume":"8","author":"Federici","year":"2002","journal-title":"Haemophilia"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB19|cit19","first-page":"29","article-title":"Update on the management of von Willebrand disease","volume":"6","author":"Federici","year":"2008","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1538-7836.2007.02562.x","article-title":"Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin): a prospective study of 50 patients","volume":"5","author":"Borel-Derlon","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-0037-1613225","article-title":"Venous thromboembolism in von Willebrand disease","volume":"88","author":"Mannucci","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/j.1538-7836.2007.02588.x","article-title":"von Willebrand factor\/factor VIII concentrate (Haemate P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery","volume":"5","author":"Lethagen","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM199503093321003","article-title":"Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group","volume":"332","author":"Thompson","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1161\/STROKEAHA.110.586289","article-title":"High von Willebrand factor levels increase the risk of stroke: the Rotterdam study","volume":"41","author":"Wieberdink","year":"2010","journal-title":"Stroke"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1055\/s-0038-1656120","article-title":"Von Willebrand factor and factor VIII\/C in acute cerebrovascular disease","volume":"77","author":"Catto","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/01.CIR.0000112567.53841.10","article-title":"Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis. Results from a multicenter study in 47 patients","volume":"109","author":"Sramek","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1177\/1076029607303613","article-title":"Type IIB von Willebrand disease: role of qualitative defects in atherosclerosis and endothelial dysfunction","volume":"13","author":"Bilora","year":"2007","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2141.1989.tb06277.x","article-title":"Mortality and causes of death in Dutch haemophiliacs, 1973-86","volume":"71","author":"Rosendaal","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2141.1990.tb07793.x","article-title":"Haemophilia protects against ischaemic heart disease: a study of risk factors","volume":"75","author":"Rosendaal","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0140-6736(03)14021-4","article-title":"Decreased mortality of ischaemic heart disease among carriers of haemophilia","volume":"362","author":"Sr\u00e1mek","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood-2006-10-050435","article-title":"Mortality rates, life expectancy, and causes of death in people with haemophilia A or B in the United Kingdom who were not infected with HIV","volume":"110","author":"Darby","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ajh.20339","article-title":"Prevalence and risk factors for heart disease among males with hemophilia","volume":"79","author":"Kulkarni","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1600-0609.2011.01611.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1517\/14740330902719481","article-title":"The safety of plasma-derived von Willebrand\/factor VIII concentrates in the management of inherited von Willebrand disease","volume":"8","author":"Federici","year":"2009","journal-title":"Expert Opin Drug Saf"},{"issue":"Suppl. 3","key":"10.1111\/j.1600-0609.2011.01611.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1365-2516.1998.0040s3048.x","article-title":"Clinical management of patients with von Willebrand disease with a VHP VWF concentrate: the France experience","volume":"4","author":"Goudemand","year":"1998","journal-title":"Haemophilia"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.2011.01611.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0609.2011.01611.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T05:27:13Z","timestamp":1625635633000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.2011.01611.x"}},"subtitle":["Change of VWD with age?"],"short-title":[],"issued":{"date-parts":[[2011,5,17]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.2011.01611.x","relation":{},"ISSN":["0902-4441"],"issn-type":[{"value":"0902-4441","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5,17]]}}}